Role of Disease Severity in Topical vs Systemic AD Treatment

Drs Alexandra Golant and Brett King discuss the role that atopic disease severity and treatment resistance play in the selection of oral vs systemic treatment for their patients.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.